IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 97 filers reported holding IGM BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,649 | -91.0% | 437 | -90.0% | 0.00% | – |
| Q2 2023 | $40,446 | +216.2% | 4,382 | +370.7% | 0.00% | – |
| Q1 2023 | $12,792 | +8.2% | 931 | +34.0% | 0.00% | – |
| Q4 2022 | $11,822 | -30.5% | 695 | -6.2% | 0.00% | – |
| Q3 2022 | $17,000 | -26.1% | 741 | -43.7% | 0.00% | – |
| Q2 2022 | $23,000 | -68.1% | 1,315 | -51.2% | 0.00% | – |
| Q1 2022 | $72,000 | -94.5% | 2,694 | -93.9% | 0.00% | -100.0% |
| Q4 2021 | $1,301,000 | -2.7% | 44,362 | +118.3% | 0.00% | 0.0% |
| Q3 2021 | $1,337,000 | -60.4% | 20,325 | -49.9% | 0.00% | -50.0% |
| Q2 2021 | $3,377,000 | -6.5% | 40,592 | -13.8% | 0.00% | 0.0% |
| Q1 2021 | $3,612,000 | +953.1% | 47,104 | +1110.3% | 0.00% | – |
| Q4 2020 | $343,000 | +757.5% | 3,892 | +623.4% | 0.00% | – |
| Q3 2020 | $40,000 | -89.7% | 538 | -89.9% | 0.00% | – |
| Q2 2020 | $388,000 | +367.5% | 5,319 | +259.4% | 0.00% | – |
| Q1 2020 | $83,000 | +118.4% | 1,480 | +48.9% | 0.00% | – |
| Q4 2019 | $38,000 | – | 994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $97,797,000 | 2.22% |
| Artal Group S.A. | 1,500,000 | $43,995,000 | 1.19% |
| Cormorant Asset Management, LP | 500,000 | $14,665,000 | 0.87% |
| Eagle Bay Advisors LLC | 34,835 | $1,022,000 | 0.65% |
| ENTRUST GLOBAL PARTNERS L L C | 66,172 | $1,940,000 | 0.54% |
| Baker Brothers Advisors | 3,156,102 | $92,568,000 | 0.45% |
| Bruce & Co., Inc. | 55,000 | $1,613,000 | 0.32% |
| Woodline Partners LP | 403,401 | $11,832,000 | 0.17% |
| Virtus ETF Advisers LLC | 5,787 | $170,000 | 0.06% |
| Alkeon Capital Management | 939,035 | $27,542,000 | 0.05% |